Day: April 18, 2019

One of the reasons patients participate in clinical trials, particularly pivotal (Phase 3) trials, is to get access to new medication not yet approved. For many patients, particularly with life-threatening diseases who have exhausted all available therapies, a clinical trial may offer the only option available for potential benefit. And many times, it works. The … Read more

Earlier this year, FDA had announced that it would publish a list of unlawful ingredients in dietary supplements, and this week it did. FDA’s list contains four ingredients. The list appears pretty underwhelming particularly because it was highlighted with an accompanying blog by FDA’s Deputy Commissioner for Food Policy. It is hard to imagine that … Read more